Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J.

Support Care Cancer. 2017 Oct;25(10):3171-3179. doi: 10.1007/s00520-017-3725-5. Epub 2017 Apr 22.

PMID:
28434095
2.

The prevalence of sacroiliac joint degeneration in asymptomatic adults.

Eno JJ, Boone CR, Bellino MJ, Bishop JA.

J Bone Joint Surg Am. 2015 Jun 3;97(11):932-6. doi: 10.2106/JBJS.N.01101.

PMID:
26041855
3.

A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.

Gilbert J, Schell MJ, Zhao X, Murphy B, Tanvetyanon T, Leon ME, Neil Hayes D, Haigentz M Jr, Saba N, Nieva J, Bishop J, Sidransky D, Ravi R, Bedi A, Chung CH.

Oral Oncol. 2015 Apr;51(4):376-82. doi: 10.1016/j.oraloncology.2014.12.011. Epub 2015 Jan 13.

4.

Lyn deficiency leads to increased microbiota-dependent intestinal inflammation and susceptibility to enteric pathogens.

Roberts ME, Bishop JL, Fan X, Beer JL, Kum WW, Krebs DL, Huang M, Gill N, Priatel JJ, Finlay BB, Harder KW.

J Immunol. 2014 Nov 15;193(10):5249-63. doi: 10.4049/jimmunol.1302832. Epub 2014 Oct 22.

5.

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial.

Hill MD, Martin RH, Mikulis D, Wong JH, Silver FL, Terbrugge KG, Milot G, Clark WM, Macdonald RL, Kelly ME, Boulton M, Fleetwood I, McDougall C, Gunnarsson T, Chow M, Lum C, Dodd R, Poublanc J, Krings T, Demchuk AM, Goyal M, Anderson R, Bishop J, Garman D, Tymianski M; ENACT trial investigators.

Lancet Neurol. 2012 Nov;11(11):942-50. doi: 10.1016/S1474-4422(12)70225-9. Epub 2012 Oct 8.

PMID:
23051991
6.

The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Bishop JL, Sly LM, Krystal G, Finlay BB.

Infect Immun. 2008 Jul;76(7):2913-22. doi: 10.1128/IAI.01596-07. Epub 2008 Apr 21.

7.

Deception point: peptidoglycan modification as a means of immune evasion.

Bishop JL, Boyle EC, Finlay BB.

Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):691-2. Epub 2007 Jan 12. No abstract available.

8.

Salmonella: from pathogenesis to therapeutics.

Boyle EC, Bishop JL, Grassl GA, Finlay BB.

J Bacteriol. 2007 Mar;189(5):1489-95. Epub 2006 Dec 22. Review. No abstract available.

9.

Friend or foe? Antimicrobial peptides trigger pathogen virulence.

Bishop JL, Finlay BB.

Trends Mol Med. 2006 Jan;12(1):3-6. Epub 2005 Nov 17.

PMID:
16298161
10.

Comparative study of a semisynthetic derivative of natamycin and the parent antibiotic on the spoilage of shredded cheddar cheese.

Suloff EC, Marcy JE, Hackney CR, Sumner SS, Bishop JR.

J Food Prot. 2003 Aug;66(8):1499-502.

PMID:
12929846
11.

A phase I trial of docetaxel and gemcitabine in patients with advanced cancer.

Rischin D, Boyer M, Smith J, Millward M, Michael M, Bishop J, Zalcberg J, Davison J, Emmett E, McClure B.

Ann Oncol. 2000 Apr;11(4):421-6.

PMID:
10847460
12.

Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancer.

Michael M, Toner GC, Olver IN, Fenessy A, Bishop JF.

Am J Clin Oncol. 1997 Jun;20(3):259-62.

PMID:
9167749
13.

Australian multicentre phase II trial of paclitaxel in women with metastatic breast cancer and prior chemotherapy.

Michael M, Bishop JF, Levi JA, Bell DR, Zalcberg JR, Friedlander ML, Olver IN, Smith JG, Toner GC.

Med J Aust. 1997 May 19;166(10):520-3.

PMID:
9196484
14.

Phase-I study of synthetic muc1 peptides in breast-cancer.

Xing P, Michael M, Apostolopoulos V, Prenzoska J, Marshall C, Bishop J, McKenzie I.

Int J Oncol. 1995 Jun;6(6):1283-9.

PMID:
21556671
15.

The immunogenicity of MUC1 peptides and fusion protein.

Apostolopoulos V, Pietersz GA, Xing PX, Lees CJ, Michael M, Bishop J, McKenzie IF.

Cancer Lett. 1995 Mar 23;90(1):21-6.

PMID:
7720038

Supplemental Content

Loading ...
Support Center